trending Market Intelligence /marketintelligence/en/news-insights/trending/X0l2cVABN9l5osmbMZDx6Q2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Hitachi confirms sale of chemical unit to Showa Denko with ¥494B deal


What’s the Bottom Line: Credit Impact of COVID-19 on US Municipals


Banking Essentials Newsletter - February Edition, Part 2


Episode 1: Origins of 451 Research - Part 1


Episode 3: Transformation of Customer Experience in 2020

Hitachi confirms sale of chemical unit to Showa Denko with ¥494B deal

Hitachi Ltd. announced Dec. 18 that it has agreed to sell its entire stake in Hitachi Chemical Co. Ltd. to Showa Denko K.K. subsidiary HC Holdings K.K. in a roughly ¥494 billion deal, confirming earlier reports.

Under the deal terms, Hitachi will sell all of its 106,699,955 shares in the chemical unit, translating to a more than 51% stake, at ¥4,630 apiece, in response to the Japanese chemical company's tender offer, which is expected to begin in February 2020 and extend for a period of 20 days.

The sale of its chemical unit, which provides semiconductor-related products, would allow Hitachi to focus on the manufacture of high-functional materials.

Following the transaction, which Hitachi expects to conclude by the next fiscal year, the Japanese industrial conglomerate estimates extraordinary gains of ¥478.0 billion on the sale. It also expects to post ¥278.0 billion in gains on business reorganization and other transactions.

Hitachi reportedly initiated the sale process in July.

The sale of Hitachi's chemical arm comes shortly after a ¥179 billion sale of its diagnostic imaging device unit to FUJIFILM Holdings Corp. as the company accelerates its efforts to reorganize its business.

As of Dec. 17, US$1 was equivalent to ¥109.53.